EvoPlexus Medics ApS: Financial statements 2024
CVR: 40782001
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
EvoPlexus Medics ApS (CVR 40782001) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -38,731 and a net result of DKK -38,945 compared with DKK -65,090 the year before. Equity in the 2024 report amounted to DKK -199,105.
- Gross Profit
- DKK -38,731
- Profit/Loss
- DKK -38,945
- Equity
- DKK -199,105
- Total Assets
- DKK 6,077
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -39 t. | -39 t. | -199 t. | - |
| 2023 | - | -65 t. | -65 t. | -160 t. | - |
| 2022 | - | -78 t. | -78 t. | -95 t. | - |
| 2021 | - | -47 t. | -47 t. | -17 t. | 0 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
EvoPlexus Medics ApS has published its annual report for 2023. Gross profit came to DKK -65,066, and the net result was DKK -65,090.
About EvoPlexus Medics ApS
EvoPlexus Medics ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2019. The company is registered under the industry Computerprogrammering. The management consists of Serkawt Khola. The company is owned by EvoPlexus Holding ApS. According to the 2021 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -50,496 and a net result of DKK -50,498 compared with DKK -38,945 the year before. Equity in the 2025 report amounted to DKK -249,603.